Cargando…
Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease
Autores principales: | Ravasio, Roberto, Giacomelli, Roberto, Bianchi, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AboutScience
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677597/ https://www.ncbi.nlm.nih.gov/pubmed/36643911 http://dx.doi.org/10.33393/grhta.2020.2187 |
Ejemplares similares
-
Analisi di budget impact di anakinra nel trattamento della Malattia di Still in Italia
por: Ravasio, Roberto, et al.
Publicado: (2020) -
Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy
por: Caporali, Roberto, et al.
Publicado: (2022) -
Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy
por: Aiello, A, et al.
Publicado: (2023) -
Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019) -
Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)